TY  - JOUR
AU  - Sara M. B. Cunha, 
AU  - Maria C. F. Carneiro, 
AU  - Cátia D. Rodrigues, 
AU  - Cátia L. S. N. S. Rasteiro, 
AU  - Teresa P. Teles, 
PY  - 2020/07/03
Y2  - 2024/10/12
TI  - Inflammatory bowel disease and women’s sexual and reproductive health: a narrative review
JF  - Ïã¸ÛÁùºÏ²Ê¿ª½±½á¹û
JA  - BJHBS
VL  - 19
IS  - 1
SE  - Literature Review
DO  - 10.12957/bjhbs.2020.53531
UR  - /bjhbs/article/view/111
SP  - 48-56
AB  - <p>Introduction: Inflammatory bowel disease is a chronic idiopathic condition involving the gastrointestinal tract. The disease prevalence is increasing worldwide, affecting women in childbearing age. Objective: Clinical and practical review of the women´s sexual and reproductive health in inflammatory bowel disease with focus in gynaecological and obstetrical management. Materials and Methods: In this article we review sexual and reproductive health issues in women with inflammatory bowel disease in all life stages and the main particularities of the approach of inflammatory bowel disease in pregnancy and breastfeeding. Results and Conclusion: Fertility in women without disease activity is not decreased comparing to general population, but despite research is inconsistent there are reports of increased risk of small for gestational age, preterm delivery, low Apgar score, congenital anomalies, intrauterine death, miscarriage, venous thromboembolism and preeclampsia. To improve obstetric outcomes, a period of 3 to 6 months of disease remission is recommended before conception. Medication adjustment may be necessary, and supplementation should be adapted. A multidisciplinary approach and a comprehensive knowledge of the disease through all women life stages allows a better health care.</p>
ER  -